TrialLancet (London, England)2005

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

John A Dormandy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.